tiprankstipranks
AEON Biopharma (AEON)
XASE:AEON
US Market
AEON
AEON Biopharma
RESEARCH TOOLSreports

AEON Biopharma (AEON) Financial Statements

223 Followers

AEON Biopharma Financial Overview

AEON Biopharma's market cap is currently $21.25M. The company's EPS TTM is $-5.24; its P/E ratio is -0.09; AEON Biopharma is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -78.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -16.90M$ 72.98M$ -348.09M$ -48.43M$ -65.85M
EBITDA$ -16.82M$ -27.73M$ -52.74M$ -48.36M$ -36.88M
Net Income$ -39.22M$ 42.01M$ -384.63M$ -52.56M$ -55.64M
Balance Sheet
Cash & Short-Term Investments$ 3.01M$ 13.00K$ 5.16M$ 9.75M$ 5.13M
Total Assets$ 5.56M$ 3.14M$ 6.84M$ 10.78M$ 6.44M
Total Debt$ 35.74M$ 12.96M$ 278.00K$ 131.53M$ 86.89M
Net Debt$ 32.74M$ 12.94M$ -4.88M$ 121.79M$ 81.76M
Total Liabilities$ 60.59M$ 31.71M$ 159.89M$ 281.19M$ 230.26M
Stockholders' Equity$ -55.03M$ -28.57M$ -153.04M$ -287.50M$ -234.94M
Cash Flow
Free Cash Flow$ -17.31M$ -20.29M$ -47.83M$ -35.89M$ -28.60M
Operating Cash Flow$ -17.31M$ -20.29M$ -47.83M$ -35.58M$ -28.43M
Investing Cash Flow$ -4.00K$ 0.00$ 0.00$ -306.00K$ -170.00K
Financing Cash Flow$ 20.30M$ 15.15M$ 14.00M$ 40.51M$ 13.56M
Currency in USD

AEON Biopharma Earnings and Revenue History

Income Statement >

AEON Biopharma Debt to Assets

Balance Sheet >

AEON Biopharma Cash Flow

Cash Flow >

AEON Biopharma Forecast EPS vs Actual EPS

Earnings >